Assessment of Plasma Fatty Acids and Sterols in Sudden - and Gradual - Onset Chronic Fatigue Syndrome Patients

References

• Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: A comprehensiv e approach to its definition and study. Ann Intern Med 1994; 121: 953–9.
   PubMed Web of Science ®Google Scholar
• Demitrack MA, Gold PW, Dale JK, et al. Plasma and cerebrospina l fluid monoamine metabolism in patients with chronic fatigue syndrome: preliminar y findings. Biol Psychiatry 1992; 32: 1065–77.
   PubMed Web of Science ®Google Scholar
• McGregor NR, Dunstan RH, Zerbes M, et al. Preliminar y determinatio n of a molecular basis to chronic fatigue syndrome. Biochem Molecul Med 1996; 57: 73–80.
   PubMedGoogle Scholar
• McGregor NR, Dunstan RH, Zerbes M, et al. Preliminary determinatio n of the associatio n between symptom expressio n and urinary metabolite s in subject s with chronic fatigue syndrome. Biochem Molecul Med 1996; 57: 73–80.
   PubMedGoogle Scholar
• Levy JA. Viral Studies of chronic fatigue syndrome. Clin Infect Dis 1994; 18: S117–20.
   PubMed Web of Science ®Google Scholar
• Natelson BH, Ye N, Moul DE, et al. High titers of anti-Epstein-Bar r virus DNA polymerase are found in patients with severe fatiguin g illness. J Med Virol 1994; 42: 42–6.
   PubMed Web of Science ®Google Scholar
• Woodward CG, Cox RA. Epstein-Barr virus serolog y in the chronic fatigue syndrome. J Infect 1992; 24: 133–9.
   PubMed Web of Science ®Google Scholar
• Buchwald D, Cheney PR, Peterson DL, et al. A chronic illness characterize d by fatigue, neurologi c and immunologic disorders, and active human herpesviru s type 6 infection. Ann Intern Med 1992; 116: 103–13.
   PubMed Web of Science ®Google Scholar
• Suhadolni k RJ, Reichenbac h NL, Hitzges P, et al. Upregulatio n of the 2–5A Synthetase/RNase L pathway associated with chronic fatigue syndrome. Clin Infect Dis 1994; 18: S96–S104.
   PubMed Web of Science ®Google Scholar
• Behan PO, Behan WM, Horrobin D. Effect of high doses of essentia l fatty acids on the postvira l fatigue syndrome. Acta Neurol Scand 1990; 82(3): 209–16.
   PubMed Web of Science ®Google Scholar
• Williams LL, Doody DM, Horrocks LA. Serum fatty acid proportion s are altered during the year following acute Epstein-Bar r virus infection. Lipids 1988; 23(10): 981–8.
   PubMed Web of Science ®Google Scholar
• Odeleye OE, Eskelson CD, Watson RR. Changes in hepatic lipid compositio n after infectio n by LP-BM5 murine leukemia virus causing murine AIDS. Life Sci 1992; 51(2): 129–34.
   PubMed Web of Science ®Google Scholar
• Peck MD, Mantero Atienza E, Miguez Burbano MJ, et al. The esterified plasma fatty acid profile is altered in early HIV-1 infection. Lipids 1993; 28(7): 593–7.
   PubMed Web of Science ®Google Scholar
• AbuBakar S, Boldogh I, Albrecht T. Human cytomegalovirus. Stimulation of [3H] release from [3H]-arachidoni c acid prelabelle d cells. Arch Virol 1990; 113: 255–66.
   Google Scholar
• Pernas P, Masliah J, Olivier JL, et al. Type II phospholipas e A2 recombinan t overexpressio n enhances stimulated arachidoni c acid release. Biochem Biophys Res Commun 1991; 178(3): 1298–305.
   PubMedGoogle Scholar
• Palumbo GJ, Glasgow WC, Buller RM. Poxvirus-induce d alteration of arachidonat e metabolism. Proc Natl Acad Sci USA 1993; 90(5): 2020–4.
   PubMed Web of Science ®Google Scholar
• Dixon RM, Borden EC, Keim NL, et al. Decreases in serum high-density-lipoprotei n cholestero l and total cholestero l resultin g from naturall y produced and recombinan t DNA-derived leukocyt e interferons. Metabolis m 1984; 33: 400–4.
   PubMed Web of Science ®Google Scholar
• Pfeffer LM, Kwok BC, Landsberger FR, Tamm I. Interfero n stimulates cholestero l and phosphatidyl - choline synthesi s but inhibits cholestero l ester synthesis in HeLa-S3 cells. Proc Natl Acad Sci USA 1985; 82: 2417–21.
   PubMedGoogle Scholar
• Miettinen TA, Tilvis RS, Kesaniem i YA. Serum plant sterols and cholestero l precursor s reflect cholestero l absorptio n and synthesi s in volunteer s of a randomly selected male population. Am J Epidemiol 1990; 131(1): 20–31.
   Google Scholar
• Fischer DG, Movick D, Cohen B, Rubinstei n M. Isolatio n and characterizatio n of a soluble form of the LDL receptor, an interferon induced antivira l protein. Proc Soc Exp Biol Med 1994; 206: 228–32.
   Google Scholar
• Gilliam AG. Epidemiologica l study of an epidemic, diagnosed as poliomyelitis, occuring among the personne l of the Los Angeles County General Hospital during the summer of 1934. Public Health Bulletin No. 240.
   Google Scholar
• Dunstan RH, McGregor NR, Watkins JA, et al. Changes in plasma lipid homeostasi s observed in chronic fatigue syndrome patients. J Nutr Environ Med 1999; 9(4): 267–80.
   Google Scholar
• Holmes GP, Kaplan JE, Gantz NM, et al. Chronic fatigue syndrome: A working case definition. Ann Intern Med 1988; 108: 387–9.
   PubMed Web of Science ®Google Scholar
• Stenson WF, Seetharam B, Talkad V, et al. Effects of dietar y fish oil supplementatio n on membrane fluidity and enzyme activity in rat small intestine. Biochem J 1989; 263: 41–5.
   PubMed Web of Science ®Google Scholar
• Davis FB, Davis PJ, Blas SD, Schoenl M. Action of long-chai n fatty acids in vitro on Ca2 1 -stimu- latable, Mg2 1 -dependen t ATPase activity in human red cell membranes. Biochem J 1987; 248: 511–16.
   PubMedGoogle Scholar
• Swarts HG, Schuurmans Stekhoven FM, De Pont JJ. Binding of unsaturate d fatty acids to Na 1, K(1) ATPase leading to inhibitio n and inactivation. Biochim Biophys Acta 1990; 1024: 32–40.
   Google Scholar
• [27] Alam SQ, Ren YF, Alam BS. Effect of dietary trans fatty acids on some membrane-associate d enzymes and receptor s in rat heart. Lipids 1989; 24: 39–44.
   Google Scholar
• Yamamoto T, Yamamoto S, Manganiell o VC, Vaughan M. Effects of fatty acids on activity of cGMP-stimulated cyclic nucleotide phosphodiesteras e from calf liver. Arch Biochem Biophys 1984; 229: 81–9.
   Google Scholar
• Leach KL, Blumberg PM. Modulation of protein kinase C activity and [3H]phorbol 12, 13-dibutyrat e binding by various tumor promoters in mouse brain cytosol. Cancer Res 1985; 45: 1958–63.
   PubMed Web of Science ®Google Scholar
• Doolan CM, Keenan AK. Inhibitio n by fatty acids of cyclic AMP-dependen t protein kinase activity in brush border membranes isolated from human placental vesicles. Br J Pharmacol 1994; 111: 509–14.
   PubMed Web of Science ®Google Scholar
• Ballou LR, Cheung WY. Inhibitio n of human platelet phospholipas e A2 activity by unsaturate d fatty acids. Proc Natl Acad Sci USA 1985; 82: 371–5.
   PubMedGoogle Scholar
• Remmers AE, Nordby GL, Medzihradsk y F. Modulation of opioid recepto r binding by cis and trans fatty acids. J Neurochem 1990; 55: 1993–2000.
   Google Scholar
• Wiersinga WM, Chopra IJ, Teco GN. Inhibition of nuclear T3 binding by fatty acids. Metabolism 1988; 37: 996–1002.
   PubMed Web of Science ®Google Scholar
• Svedberg J, Bjorntorp P, Smith U, Lonnroth P. Free-fatty acid inhibitio n of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes 1990; 39: 570–4.
   PubMed Web of Science ®Google Scholar
• Liang T, Liao S. Inhibitio n of steroid 5 alpha-reductas e by specific aliphati c unsaturate d fatty acids. Biochem J 1992; 285: 557–62.
   PubMedGoogle Scholar
• De Schrijver R, Privett OS. Interrelationshi p between dietary trans fatty acids and the 6-and 9-desaturase s in the rat. Lipids 1982; 17: 27–34.
   PubMed Web of Science ®Google Scholar
• Rosenthal MD, Whitehurst MC. Selective effects of isomeric cis and trans fatty acids on fatty acyl delta 9 and delta 6 desaturatio n by human skin fibroblasts. Biochim Biophys Acta 1983; 753: 450–9.
   Google Scholar
• Rosenthal MD, Doloresco MA. The effects of trans fatty acids on fatty acyl delta 5 desaturatio n by human skin fibroblasts. Lipids 1984; 19: 869–74.
   Google Scholar
• Nestel PJ, Noakes M, Belling GB, et al. Plasma cholesterol-lowerin g potentia l of edible-oi l blends suitable for commercial use. Am J Clin Nutr 1992; 55: 46–50.
   PubMed Web of Science ®Google Scholar
• Abbey M, Nestel PJ. Plasma cholestery l ester transfer protein activity is increase d when trans-elaidi c acid is substitute d for cis-olei c acid in the diet. Atherosclerosi s 1994; 106: 99–107.
   Google Scholar
• Sugano M, Ryu K, Ide T. Cholestero l dynamics in rats fed cis- and trans-octadecenoat e in the form of triglyceride. J Lipid Res 1984; 25: 474–85.
   PubMedGoogle Scholar
• Urade R, Kito M. Phospholipi d metabolism in V79-R membranes composed of phospholipi d molecular species containin g trans-monoenoi c fatty acids. J Biochem Tokyo 1984; 96: 821–8.
   PubMed Web of Science ®Google Scholar
• Hillmar I, Henze K, Zollner N. Influence of fatty acids on microsomal diacylglycero l acyltransferas e activity in primary culture s of hepatocytes. Hoppe Seylers Z Physiol Chem 1983; 364: 173–8.
   PubMedGoogle Scholar
• Ide T, Watanabe M, Sugano M, Yamamoto I. Activities of liver mitochondria l and peroxisoma l fatty acid oxidation enzymes in rats fed trans fat. Lipids 1987; 22: 6–10.
   PubMed Web of Science ®Google Scholar
• Takenawa T, Nagai Y. Effect of unsaturate d fatty acids and Ca2 1 on phosphatidylinosito l synthesi s and breakdown. J Biochem Tokyo 1982; 91: 793–9.
   PubMedGoogle Scholar
• Kritchevsky D. Trans fatty acid effects in experimenta l atherosclerosis. Fed Proc 1982; 41: 2813–17.
   Google Scholar
• Kido H, Fukusen N, Katunuma N. Inhibition of chymase activity by long chain fatty acids. Arch Biochem Biophys 1984; 230: 610–14.
   Google Scholar
• Stephen FD, Yokota SJ, Repasky EA. The effect of free fatty acids on spectri n organizatio n in lymphocytes. Cell Biophys 1990; 17(3): 269–82.
   PubMedGoogle Scholar
• Vincenzini MT, Favilli F, Treves C, et al. The palmitoleate: a natural selectiv e denaturan t of enzymes. Int J Biochem 1983; 15: 1283–6.
   PubMedGoogle Scholar